Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.70 is 18% below its 5-year average of 2.08, near the low end of its 5-year range (1.57–3.41).
As of the fiscal period ended Tuesday, June 30, 2026. 2.77% above its 12-month average of 1.65.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.70.
QUICK RATIO (ACID-TEST)
1.70
QUICK RATIO (ACID-TEST) AVG TTM
1.65
QUICK RATIO (ACID-TEST) AVG 3Y
1.64
QUICK RATIO (ACID-TEST) AVG 5Y
2.08
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.77%
CURRENT VS 3Y AVG
+3.36%
CURRENT VS 5Y AVG
-18.30%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 497 covered companies
CURRENT VS SECTOR MEDIAN
-43.21%
vs the sector median at left
Alignment Healthcare, Inc.
Market Cap
$1.76B
Quick Ratio (Acid-Test)
1.70
TTM Avg
1.65
3Y Avg
1.64
5Y Avg
2.08
Market Cap
$1.78B
Quick Ratio (Acid-Test)
6.65
TTM Avg
5.42
3Y Avg
7.28
5Y Avg
7.47
Market Cap
$1.78B
Quick Ratio (Acid-Test)
8.30
TTM Avg
3.78
3Y Avg
3.78
5Y Avg
3.78
Market Cap
$1.71B
Quick Ratio (Acid-Test)
1.07
TTM Avg
0.89
3Y Avg
0.95
5Y Avg
0.97
Market Cap
$1.83B
Quick Ratio (Acid-Test)
1.23
TTM Avg
1.57
3Y Avg
2.04
5Y Avg
2.44
Market Cap
$1.66B
Quick Ratio (Acid-Test)
4.69
TTM Avg
5.42
3Y Avg
2.91
5Y Avg
3.12
Market Cap
$1.87B
Quick Ratio (Acid-Test)
9.79
TTM Avg
11.31
3Y Avg
11.94
5Y Avg
12.05
Market Cap
$1.65B
Quick Ratio (Acid-Test)
2.41
TTM Avg
2.10
3Y Avg
2.35
5Y Avg
2.26
Market Cap
$1.65B
Quick Ratio (Acid-Test)
1.07
TTM Avg
1.43
3Y Avg
1.49
5Y Avg
1.78
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alignment Healthcare, Inc. (ALHC) | $1.76B | 1.70 | 1.65 | 1.64 | 2.08 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | 6.65 | 5.42 | 7.28 | 7.47 |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | 8.30 | 3.78 | 3.78 | 3.78 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 1.07 | 0.89 | 0.95 | 0.97 |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.23 | 1.57 | 2.04 | 2.44 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.66B | 4.69 | 5.42 | 2.91 | 3.12 |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | 9.79 | 11.31 | 11.94 | 12.05 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 2.41 | 2.10 | 2.35 | 2.26 |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 1.07 | 1.43 | 1.49 | 1.78 |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 7.14 | 4.14 | 3.11 | 3.56 |
Quick Ratio
1.70
Excludes inventory
Current Ratio
1.70
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.70 |
| 2026-03-31 | 1.58 |
| 2025-12-31 | 1.71 |
| 2025-09-30 | 1.61 |
| 2025-06-30 | 1.66 |
| 2025-03-31 | 1.69 |
| 2024-12-31 | 1.88 |
| 2024-09-30 | 1.60 |
| 2024-06-30 | 1.61 |
| 2024-03-31 | 1.57 |
| 2023-12-31 | 1.84 |
| 2023-09-30 | 1.63 |
| 2023-06-30 | 1.70 |
| 2023-03-31 | 1.79 |
| 2022-12-31 | 2.37 |
| 2022-09-30 | 2.03 |
| 2022-06-30 | 2.74 |
| 2022-03-31 | 2.90 |
| 2021-12-31 | 3.31 |
| 2021-09-30 | 3.30 |
| 2021-06-30 | 3.41 |
| 2021-03-31 | 3.56 |
| 2020-12-31 | 1.72 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
